Zymergen (Zymergen) Interest Expense : $-26.63 Mil (TTM As of Jun. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Zymergen Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Zymergen's interest expense for the three months ended in Jun. 2022 was $ -9.38 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2022 was $-26.63 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Zymergen's Operating Income for the three months ended in Jun. 2022 was $ -65.74 Mil. Zymergen's Interest Expense for the three months ended in Jun. 2022 was $ -9.38 Mil. Zymergen did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zymergen Interest Expense Historical Data

The historical data trend for Zymergen's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymergen Interest Expense Chart

Zymergen Annual Data

Trend

Dec19

Dec20

Dec21

Interest Expense

-2.94

-10.96

-14.71

Zymergen Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Interest Expense	Get a 7-Day Free Trial						-2.77	-2.81	-6.40	-8.05	-9.38

Zymergen Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.63 Mil.

Zymergen (NAS:ZY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zymergen's Interest Expense for the three months ended in Jun. 2022 was $-9.38 Mil. Its Operating Income for the three months ended in Jun. 2022 was $-65.74 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2022 was $178.18 Mil.

Zymergen's Interest Coverage for the quarter that ended in Jun. 2022 is calculated as

Zymergen did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Zymergen (Zymergen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608

Website

https://www.zymergen.com

Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

Executives

Enakshi Singh	officer: Chief Financial Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Mina Kim	officer: Chief Legal Officer	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Zachariah Serber	director, officer: Chief Science Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Aaron Kimball	officer: Chief Technology Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94025
Jay T Flatley	director	9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Svf Excaliber (cayman) Ltd	10 percent owner	27 HOSPITAL ROAD, WALKERS CORPORATE LTD., CAYMAN CORPORATE CENTRE, GEORGE TOWN, GRAND CAYMAN E9 KY-9008
Josh Hoffman	director, officer: Chief Executive Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Erik Jedidiah Dean	officer: VP Operations and Engineering	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Rohit Sharma	director	575 HIGH STREET PALO ALTO CA 94301
Travis Murdoch	director	1 CIRCLE STAR WAY SAN CARLOS CA 94070
Matthew Ocko	director	270 UNIVERSITY AVENUE, PALO ALTO CA 94301
Svf Endurance (cayman) Ltd	10 percent owner	C/O WALKERS CORPORATE LIMITED, 27 HOSPITAL ROAD, GEORGE TOWN E9 KY1-9008
Softbank Vision Fund (aiv M1) L.p.	10 percent owner	251 LITTLE FALLS DRIVE, WILMINGTON DE 19808
Sb Investment Advisers (uk) Ltd	10 percent owner	69 GROSVENOR STREET, LONDON X0 W1K 3JP
Christine Marie Gorjanc	director	4500 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054